Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of Nɛ-carboxymethyl lysine-Reference-Cited by-同舟云学术

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of Nɛ-carboxymethyl lysine

Published:2010-11 Issue:6 Volume:24 Page:424-432
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Kawai Toshihide,Takei Izumi,Tokui Mikiya,Funae Osamu,Miyamoto Kazunori,Tabata Mitsuhisa,Hirata Takumi,Saruta Takao,Shimada Akira,Itoh Hiroshi

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference52 articles.

1. Identification of Nɛ-carboxymethyllysine as a degeneration product of fructoselysine in glycated protein;Ahmed;Journal of Biological Chemistry,1986

2. F-Wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus;Andersen;Muscle & Nerve,1997

3. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy;Ando;Journal of Diabetes and its Complications,2006

4. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm;Baynes;Diabetes,1999

5. Circulating cell adhesion molecules and death in patients with coronary artery disease;Blankenberg;Circulation,2001

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic syndrome and neuroprotection;SCT Proceedings in Interdisciplinary Insights and Innovations;2024-06-12

2. Aldose reductase is a potential therapeutic target for neurodegeneration;Chemico-Biological Interactions;2024-02

3. Cemtirestat, an aldose reductase inhibitor and antioxidant compound, induces ocular defense against oxidative and inflammatory stress in rat models for glycotoxicity;Cell Biochemistry and Function;2023-06-05

4. Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke;Biomolecules;2022-11-18

5. Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG);International Journal of Molecular Sciences;2022-08-05